First decide what you want to improve
Sleep supplements are not one treatment. They include a hormone such as melatonin, a nutrient such as magnesium, amino acids and plant extracts. Their ingredients, purposes and safety questions differ. A product sold for sleep can be easy to buy without being a well-supported treatment for insomnia. [1, 2, 3, 4]
This comparison is for adults. It separates ordinary dissatisfaction with sleep from insomnia and problems with sleep timing. Insomnia means difficulty sleeping despite having the opportunity, with effects during the day. A body clock that is out of step with the required schedule asks a different question. The guide to sleeping better helps make that distinction; jet lag needs its own timing plan. [1, 4]
Falling asleep
Staying asleep
Functioning tomorrow
For chronic insomnia, cognitive behavioural therapy for insomnia, usually shortened to CBT-I, remains first-line care. It is a structured treatment addressing sleep habits, time in bed and thoughts about sleep. A supplement is not an established equivalent. [1, 2]
Compare the main ingredients
Melatonin comes first for its specific supported uses. Magnesium, L-theanine, glycine and ashwagandha remain exploratory sleep options; valerian has less support for routine insomnia use. This is an editorial order for comparing ingredients in adults. It is not a claim that each entry works better than the next, or a list of six things to take together.
The sleep problem changes the starting point:
| What you want to address | Where to start | Why the distinction matters |
|---|---|---|
| Jet lag or a diagnosed sleep-timing problem | Melatonin's specific uses and the jet-lag guide | Timing instructions belong to the indication. |
| Primary insomnia at age 55 or over | The specific prolonged-release melatonin medicine and local care guidance | A result for this medicine is not a result for every melatonin supplement. |
| Persistent insomnia with daytime consequences | CBT-I and assessment | The first item in a supplement list is not automatically the first-line treatment. |
| General poor sleep and interest in a supplement | Read the limited-evidence group below after checking routines and possible causes | There is no demonstrated best supplement for this broad group. |
1. Melatonin
Specific supported usesStart here for jet lag or a diagnosed sleep-timing problem. A particular prolonged-release medicine also has an older-adult insomnia indication.
- Potential advantage
- Defined uses with more specific guidance than a general promise to sleep better.
- Main limitation
- Timing and formulation matter. This is not the first-line treatment for chronic insomnia.
Read the Melatonin guideCompare all eight criteria for Melatonin
Forms and study amounts: Immediate-release and prolonged-release preparations serve different questions. The 2 mg prolonged-release Circadin result belongs to adults aged 55 and over with primary insomnia, not to every gummy or tablet.
- Efficacy
- For Circadin, 32% versus 19% improved in sleep quality and next-day function after three weeks. Jet lag and timing problems have their own evidence.
- Evidence
- Guidance and authorised medicine evidence for specific uses; chronic-insomnia guideline recommendations differ by preparation and population.
- Risks
- Drowsiness and medicine interactions; product identity and appropriate timing need checking.
- Time
- Three-week assessment in the cited Circadin result. Travel schedules are a different use, not a nightly long-term course.
- Cost
- The US example below is an ordinary supplement with other nutrients. It does not price or substitute for prolonged-release Circadin.
- Effort
- Release form, indication and clock time change the instructions; an arbitrary bedtime serving is not a travel plan.
- Maintenance
- Follow the indication and product-specific duration. Evidence for one course does not establish indefinite use or benefit after stopping.
- Access
- Sold as a supplement in the US; medicine status and prescription requirements differ elsewhere. Check the local preparation.
First because it has specific supported uses, not because it beats every other ingredient in a direct trial. [5, 6, 4, 7, 2, 1]
2. Magnesium
Limited sleep evidenceA mineral with some small or inconsistent sleep findings. Correcting low intake and treating insomnia are different questions.
- Potential advantage
- Recent trials help put the size and limits of symptom improvements into context.
- Main limitation
- No demonstrated best form for sleep, and a nutritional role does not prove an insomnia benefit.
Read the Magnesium guideCompare all eight criteria for Magnesium
Forms and study amounts: Bisglycinate, L-threonate and other salts stay under one ingredient. Compare elemental magnesium and accompanying ingredients, not the total weight of the compound.
- Efficacy
- Bisglycinate reduced symptom scores by 3.9 versus 2.3 points at four weeks. A threonate trial improved daytime impairment, but not overall sleep disturbance or wearable sleep outcomes.
- Evidence
- Mixed controlled findings, with different forms and outcomes. Small questionnaire changes are not proof of deeper sleep.
- Risks
- Digestive effects, medicine interactions and extra concern with impaired kidney function.
- Time
- Four to six weeks in the highlighted recent trials; this is follow-up duration, not a guaranteed onset.
- Cost
- The US powder example below has conflicting serving counts on its page; the price range reflects that uncertainty.
- Effort
- Read the elemental amount and all ingredients. Tablets and powders can have different serving instructions.
- Maintenance
- The sleep trials do not establish a lasting benefit after stopping or the value of indefinite nightly use.
- Access
- Check the local supplement label. Retail availability does not mean the product is authorised to treat insomnia.
First in the exploratory group because there are recent controlled poor-sleep studies to interpret. Positions within this group do not establish superiority. [8, 9, 3, 10]
3. L-theanine
Limited sleep evidenceAn amino acid studied for stress and sleep. Some parts of a sleep questionnaire improved in a small adult trial.
- Potential advantage
- A standalone trial helps separate the ingredient from the many multi-ingredient sleep blends.
- Main limitation
- The total sleep-quality score did not clearly beat placebo. Relaxation is not the same result as treating insomnia.
Read the L-theanine guideCompare all eight criteria for L-theanine
Forms and study amounts: The studied standalone amount was 200 mg before sleep each night. Tea, caffeine-containing drinks and blends are separate preparations.
- Efficacy
- Selected questionnaire parts favoured theanine; the overall score did not clearly separate from placebo.
- Evidence
- A 30-person healthy-adult crossover trial. Reviews mix populations and, in some cases, combination products.
- Risks
- Small, short trials leave long-term and special-population safety unclear. Check every ingredient in a blend.
- Time
- Four weeks per treatment in the featured standalone trial; no established best bedtime or personal time to benefit.
- Cost
- The US reference capsule below also contains inositol; its price is not the cost of the exact research tablet.
- Effort
- Check the theanine amount, caffeine and other actives. The research does not establish an optimal bedtime schedule.
- Maintenance
- A sustained benefit after stopping and long-term nightly use are not established by these trials.
- Access
- Check local availability and the actual label; an online listing is not a universal authorisation or safety assessment.
Listed before glycine because the featured adult placebo comparison followed four-week periods, while glycine's highlighted experiments lasted a few nights. This is an editorial tie-break, not proof of a stronger effect or greater safety. [11, 12, 13]
4. Glycine
Limited sleep evidenceAn amino acid with preliminary findings for sleep onset and next-day fatigue in tiny, short experiments.
- Potential advantage
- The original studies identify the measured ingredient, bedtime amount and specific outcomes.
- Main limitation
- A few nights of research cannot establish reliable treatment of persistent insomnia or long-term safety.
Read the Glycine guideCompare all eight criteria for Glycine
Forms and study amounts: The trials used 3 g of glycine before bed. Protein, collagen and magnesium glycinate are not equivalent study preparations.
- Efficacy
- Earlier sleep onset in an 11-person laboratory analysis; less first-day fatigue after shortened sleep in another tiny experiment.
- Evidence
- Preliminary original experiments. Earlier entry into deep sleep did not mean a larger proportion of the night in deep sleep.
- Risks
- Short safety observations include digestive symptoms at a higher amount; they do not establish years of nightly safety.
- Time
- A few nights, with before-bed use. No tested optimal dose or durable-benefit timeline.
- Cost
- The US example below prices three 1 g capsules as a 3 g comparison amount, not a recommended course.
- Effort
- Powder measurement or capsule count depends on the label. Total protein grams are not glycine grams.
- Maintenance
- No established continuing benefit after stopping; the evidence horizon is very short.
- Access
- Verify standalone glycine and the amount per serving on the local label; blends answer a different question.
Its narrow, very short evidence base places it later in the exploratory group; this is not a measured head-to-head disadvantage. [14, 15, 16, 17]
5. Ashwagandha
Limited sleep evidenceA plant extract with promising but preparation-specific sleep findings and additional safety questions.
- Potential advantage
- One small insomnia-and-anxiety trial measured sleep using movement monitoring as well as questionnaires.
- Main limitation
- Extracts differ, some sleep outcomes were not clearly improved, and liver and thyroid cautions matter.
Read the Ashwagandha guideCompare all eight criteria for Ashwagandha
Forms and study amounts: The highlighted trial used KSM-66 root extract, 300 mg twice daily. Root-and-leaf extracts and other strengths cannot inherit that result.
- Efficacy
- At ten weeks, mean time to fall asleep was 29 versus 33.95 minutes with placebo; total sleep and night-time wakefulness did not clearly separate.
- Evidence
- A small 60-person trial, 58 completers, with unequal groups and multiple outcomes. Reviews include overlapping evidence.
- Risks
- Liver and thyroid concerns and medicine interactions; NIH advises avoidance in pregnancy, breastfeeding and hormone-sensitive prostate cancer.
- Time
- Ten weeks in the highlighted trial; that does not establish an immediate sedative effect.
- Cost
- The US root-and-leaf example below differs from KSM-66. Its price cannot be used as the cost of the trial regimen.
- Effort
- Two daily study doses and exact extract identity. Milligrams alone do not match preparations.
- Maintenance
- The trial does not establish lasting benefit after stopping or long-term nightly safety.
- Access
- Local rules and product composition vary; check the specific extract rather than treating all ashwagandha products as interchangeable.
Placed later because extract matching and liver/thyroid cautions add decision complexity, not because its measured sleep-onset result is weaker than every ingredient above. [18, 19, 20]
6. Valerian
Not favoured for insomniaA traditional herbal sleep aid whose inconsistent findings have not established a reliable routine insomnia role.
- Potential advantage
- Human trials allow a closer look at the claim than tradition alone.
- Main limitation
- In a large remote trial the primary sleep-quality result was not clearly better than placebo; insomnia guidance advises against use.
Read the Valerian guideCompare all eight criteria for Valerian
Forms and study amounts: Root powder, extracts and tea are not one preparation. The featured trial used 600 mg extract nightly for two weeks.
- Efficacy
- Primary improvement: 28.7% versus 21.2% with placebo in the featured trial, an uncertain difference. A positive secondary answer does not replace that result.
- Evidence
- Inconsistent results across preparations; current insomnia guidance advises against routine use.
- Risks
- Possible sleepiness and additive effects with alcohol or sedatives; long-term safety remains uncertain.
- Time
- Two weeks in the featured trial; variable durations in the wider literature.
- Cost
- The US example below is root powder, not the 600 mg extract studied. A cheaper label is not evidence of equivalent effect.
- Effort
- Identify root versus extract and other ingredients. A tea serving cannot be calculated from an extract trial.
- Maintenance
- No established durable benefit after stopping and insufficient long-term safety evidence.
- Access
- Supplement and herbal-medicine labels vary by country; traditional-use registration is not proof of efficacy in this comparison.
Last because the uncertain primary outcomes and negative guideline recommendation give less reason to prioritise it for insomnia. [21, 22, 23, 2]
For a focused two-ingredient decision, magnesium versus melatonin explains their different uses and the combination evidence. The profiles above keep amounts, forms, interactions and original results attached to each ingredient.
How we order the ingredients
The eight criteria are efficacy, evidence, risks, time, cost, effort, maintenance and access. Every card uses the same eight headings. Expand a card to see the actual assessment, including facts that remain unknown.
We first ask whether there is a supported use matching the sleep problem, then consider the reliability and practical size of the benefit. Safety and the difficulty of matching the tested preparation affect editorial priority. Trial duration describes when researchers measured an outcome; it is not a promise about when someone will feel better.
Within the limited-evidence group, the order is editorial. Magnesium has recent controlled poor-sleep studies; the featured standalone theanine trial followed four-week periods, while glycine's highlighted experiments lasted a few nights. Ashwagandha's extract differences and liver/thyroid cautions add decision complexity. None of these tie-breaks establishes a head-to-head winner or comparative safety. Valerian comes last because of inconsistent primary findings and a negative insomnia-guideline recommendation. [8, 9, 13, 15, 16, 19, 20, 22, 2]
We do not average these criteria into a score. Questionnaire points, minutes to fall asleep and next-day fatigue are different outcomes. Missing long-term data are marked as unknown, not scored as zero. Prices and access depend on the market and product; the small US price sample below informs budgeting but does not determine the positions. Devices and bedroom changes stay outside this ingredient list.
What the ingredients cost
Compare the amount and preparation, not just the bottle price. The examples below show how to read a cost, with the country, date, pack and calculation visible. They do not identify the cheapest product or price a proven course of treatment. Several retail examples differ materially from the products in the trials.
See six dated US price examples
Regular US prices listed by one manufacturer, NOW Foods, checked 5 October 2026. This small convenience sample is not a market survey or a brand recommendation. Tax, delivery and temporary discounts are excluded. A serving below is a unit for arithmetic, not a sleep-treatment dose.
NOW Melatonin 1 mg Tablets
$12.99 / 100 tablets
1 tablet: 1 mg melatonin plus niacin, vitamin B6, calcium and magnesium. About $0.13 per comparison serving.
Immediate-release US supplement with cofactors, not the 2 mg prolonged-release European medicine studied for adults 55+. The cofactors matter when comparing products. [24]
NOW Magnesium Bisglycinate Powder
$23.99 / 8 oz powder
1 level teaspoon (about 3 g): 300 mg elemental magnesium. About $0.26 to $0.32 per serving, depending on the conflicting serving counts.
Supplement Facts says about 76 servings, while the same page's size table says about 91; that makes the implied serving cost about $0.26 to $0.32. The 8 oz pack and 3 g serving support about 76. This is not the 250 mg elemental-magnesium preparation used in the cited sleep trial. [25]
NOW L-Theanine, Double Strength 200 mg Veg Capsules
$25.99 / 60 capsules
1 capsule: 200 mg L-theanine plus 100 mg inositol. About $0.43 per comparison serving.
Contains inositol, so it is not the stand-alone L-theanine tablet tested in the 30-person trial. A $19.49 sale price was also visible on one manufacturer-page view; the regular $25.99 price is used here. [26]
NOW Glycine 1000 mg Veg Capsules
$18.99 / 100 capsules
3 capsules: 3 g free-form glycine. About $0.58 per comparison serving.
The label lists 33 three-capsule servings, leaving one capsule. Three grams matches the amount in short glycine sleep studies, but the studies tested flavoured preparations and do not establish this capsule's effect. [27]
NOW Ashwagandha 450 mg Veg Capsules
$9.99 / 30 capsules
1 capsule: 450 mg root-and-leaf extract, minimum 2.4% withanolides. About $0.33 per comparison serving.
Root-and-leaf extract, not the KSM-66 root extract tested at 300 mg twice daily. A $7.99 sale price was also visible on one manufacturer-page view; the regular $9.99 price is used here. [28]
NOW Valerian Root 500 mg Veg Capsules
$11.99 / 100 capsules
2 capsules: 1 g whole valerian root. About $0.24 per comparison serving.
Whole-root capsules, not the 600 mg extract tested in the two-week insomnia trial. The plant weight cannot be exchanged milligram for milligram with extract. [29]
The US supplement prices cannot stand in for medicine prices or availability in another country. In particular, the melatonin example does not price prolonged-release Circadin. A local product check comes after choosing the relevant ingredient and formulation. [6, 4]
What a better sleep score actually means
A questionnaire can measure distress about sleep, perceived quality or daytime difficulty. It does not directly measure minutes asleep. A wearable estimates sleep from signals such as movement; laboratory sleep measurements use different methods. The result needs its own name. [8, 9, 30]
For example, the newer magnesium studies do not justify a blanket claim of deeper sleep. The bisglycinate study found a small symptom-score difference. A 2026 threonate study found improvement in sleep-related daytime impairment, but not a clear difference in overall sleep disturbance or the Oura sleep outcomes. [8, 9]
Four questions that make a trial result useful
- What changed: minutes, symptoms, perceived quality or next-day function?
- Was the improvement greater than with an inactive comparison product, called a placebo?
- Was the tested preparation the same as the one being discussed?
- Were the people in the study similar to the adults the claim is aimed at?
The same caution applies to botanicals. A small ashwagandha trial found a difference in time to fall asleep after ten weeks, but not clear differences in total sleep time or time awake during the night. “Improves sleep” loses that important distinction. [19]
Does a sleep stack work better?
Adding ingredients does not establish that a product works better. A direct trial of the actual combination is more informative than separate positive studies of its components.
One six-week study randomised 64 adults with poor sleep to a drink containing L-theanine, lemon balm, valerian and saffron, or a placebo drink. Fifty-eight completed it. People with diagnosed sleep disorders were excluded. Sleep efficiency means the proportion of time in bed spent asleep; this and sleep duration were estimated by a Fitbit, rather than measured in a sleep laboratory. The active drink did not clearly outperform placebo on sleep efficiency, total sleep time or reported quality. The study was funded by Team Foods Colombia; the authors reported no sponsor role in conducting, analysing or deciding to publish it. [30]
Sleep-quality score improvement after six weeks
Four-ingredient drink31 completers
3.11points
Placebo drink27 completers
3.86points
Larger bars mean larger reductions in the Pittsburgh Sleep Quality Index, a questionnaire where lower scores indicate better sleep. Both groups improved; the difference was not statistically clear (p = 0.41). This is one formulation, not a comparison of individual ingredients. [30]
Other combinations can give different results. A small melatonin-and-magnesium trial reported benefits against placebo, but did not compare the combination with either ingredient alone. The two-ingredient comparison explains that distinction. [31]
This does not prove that every blend fails, or that its ingredients interfere with one another. It shows why promising individual ingredients cannot simply be added into a promised result. A routine built around the actual sleep problem is a clearer starting point than an expanding list of products.
What about chamomile, tart cherry, GABA and CBD?
These candidates are not all supported to the same extent, and none should inherit another ingredient’s findings. The table keeps them separate rather than treating “natural sleep aids” as one intervention.
| Ingredient | What the reviewed evidence can say | What it cannot settle |
|---|---|---|
| Chamomile | A review found a subjective-quality signal across mixed populations. | Reliable improvement in sleep duration or efficiency, or that ordinary tea treats chronic insomnia. [32, 2] |
| Tryptophan | A small pooled evidence base suggests less time awake after falling asleep. | A dependable overall sleep benefit or universal dose. Medicine interactions matter. [33, 34] |
| 5-HTP | A small older-adult study reported exploratory benefits. | A firm placebo-controlled result: its control group took no supplement. [35] |
| GABA | Some small studies suggest an effect on falling asleep. | Reliable improvement across sleep outcomes or proof that an oral supplement reproduces brain GABA activity. [36] |
| Lemon balm | Human research includes mixtures and small studies. | Reliable standalone insomnia treatment from the material reviewed here. [37, 30] |
| Passionflower | Small studies have measured sleep outcomes. | A convincing routine insomnia role; VA/DoD guidance advises against it. [37, 2] |
| Tart cherry | Two small insomnia trials were positive within a recent review. | A clear overall benefit across mixed adults, or a melatonin-equivalent juice dose. [38] |
| CBD | A small pilot was largely negative for insomnia symptoms, with one positive objective sleep-efficiency result. | A reliable insomnia treatment, equivalence to THC mixtures, or harmlessness. [39, 2, 40] |
For CBD, the FDA has also reported liver-enzyme elevations in a safety study at a different, higher dose range than the insomnia pilot. That result cannot give the risk for every gummy, but it prevents an assumption that a nonintoxicating product is automatically low-risk. [40]
How to compare products without a score
A useful label comparison starts with identity and ends with a measurable purpose. A larger milligram number, a longer ingredient list or a sleep-stage claim is not enough.
- 1
Name the problem
Distinguish sleep timing, persistent insomnia and a short period of poor sleep.
- 2
Identify the product
Record the ingredient, release form or extract, amount per serving and other active ingredients.
- 3
Check suitability
A pharmacist or clinician can review medicines, relevant health conditions and product warnings.
- 4
Define improvement
Decide whether the question concerns falling asleep, waking, daytime function or another specific outcome.

The melatonin profile explains why labelled amounts and release forms matter. The magnesium profile explains why other supplements, antacids and medicines can affect the safety calculation. Neither a certificate of product quality nor a clean label would prove that an ingredient treats insomnia. [3, 41]
Where non-supplement options fit
Bedroom changes and devices belong in a separate comparison. They should not appear as if they were extra ingredients in a supplement ranking. The bedroom-temperature guide and light-and-screens guide address environmental questions; their evidence does not turn a supplement blend into a tested combined treatment.
Choose the next question, not the longest ingredient list
The sleep guide is the next step when the cause of poor sleep is unclear. For a specific product decision, start with melatonin’s uses and labels or magnesium’s forms and trial results. For disrupted timing after travel, use the jet-lag guide.
Explore the sleep collectionFind the explanation that matches your sleep problem, from everyday changes to ingredient-specific questions.